Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.48 |
| ▸ | CDC25A | P30304 | 1/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.47 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.47 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.45 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26722458 | 1.00 | CES1 (0.48) | CES1CDC25ANR1H2NR1H3ASAH1 | |
| SCHEMBL18256567 | 1.00 | CES1 (0.48) | CES1CDC25ANR1H2NR1H3ASAH1 | |
| SCHEMBL18248457 | 1.00 | CES1 (0.48) | CES1CDC25ANR1H2NR1H3ASAH1 | |
| SCHEMBL21938958 | 0.97 | CES1 (0.46) | CES1CDC25ANR1H2NR1H3ASAH1 | |
| SCHEMBL23436530 | 0.89 | MGLL (0.45) | CES1CDC25ANR1H2NR1H3ASAH1 | |
| SCHEMBL4581089 | 0.89 | DRD3 (0.42) | CES1CDC25ANR1H2NR1H3ASAH1 | |
| SCHEMBL30054258 | 0.89 | TERT (0.42) | CES1CDC25AALDH1A1MEN1KMT2A | |
| SCHEMBL29783582 | 0.87 | ALDH1A1 (0.45) | CES1CDC25AALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL9491373 | 0.87 | ALDH1A1 (0.45) | CES1CDC25AALDH1A1ALDH2ALDH3A1 | |
| SCHEMBL28332332 | 0.87 | CYP1B1 (0.56) | ALDH1A1MEN1CYP1A2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348362-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-11-02 | — | — | US | disclosed |
| US-20230348362-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-11-02 | — | — | US | disclosed |
| US-20170044309-A1 | PREPARATION OF HIGH MOLECULAR WEIGHT POLYMERS BY DIRECT ARYLATION AND HETEROARYLATION | UNIVERSITE LAVAL (CA) | 2017-02-16 | — | — | US | disclosed |
| US-9505876-B2 | Preparation of high molecular weight polymers by direct arylation and heteroarylation | UNIVERSITE LAVAL (CA) | 2016-11-29 | — | — | US | disclosed |
| US-20140371409-A1 | PREPARATION OF HIGH MOLECULAR WEIGHT POLYMERS BY DIRECT ARYLATION AND HETEROARYLATION | UNIVERSITE LAVAL (CA) | 2014-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348362-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | CETP, NPC1, LCAT | CES1 204/4885CDC25A 4566/4885NR1H2 84/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.